ロード中...
Immunogenomics Analysis Reveals that TP53 Mutations Inhibit Tumor Immunity in Gastric Cancer()
Although immunotherapy continues to demonstrate efficacy in a variety of refractory cancers, currently, no any immunotherapeutic strategy is clinically used for gastric cancer (GC) except its microsatellite instable subtype. Thus, it is important to identify molecular biomarkers for predicting the r...
保存先:
| 出版年: | Transl Oncol |
|---|---|
| 主要な著者: | , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Neoplasia Press
2018
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6078052/ https://ncbi.nlm.nih.gov/pubmed/30059832 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.tranon.2018.07.012 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|